![](https://undark.org/wp-content/uploads/2025/02/GettyImages-2184146816_crop.jpg)
For Many, Weight-Loss Drugs Are Pricey. Expanding Access Is Hard.
In the coming year, President Donald Trump’s administration will face a choice: Spend billions of dollars to cover anti-obesity drugs under Medicare and Medicaid, or deny more than 7 million people access to a potentially lifesaving treatment. The decision …